跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LORAZEPAM AUROVITAS 0,5 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LORAZEPAM AUROVITAS 0,5 MG COMPRIMIDOS EFG
Approved
STANDARD
LORAZEPAM AUROVITAS 0,5 MG COMPRIMIDOS EFG
Aurovitas Spain, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 16, 2025
Approval ID
715b6baaaf59598c
Company
Aurovitas Spain, S.A.U.
Type
Standard
Approval Details
Approval Id
715b6baaaf59598c
Drug Cima Aemps Name
LORAZEPAM AUROVITAS 0,5 MG COMPRIMIDOS EFG
Register Number
90286
Holder Company Name
Aurovitas Spain, S.A.U.
Marketing Company Name
Aurovitas Spain, S.A.U.
Authorization Date
2025-04-16
Dosage Form
COMPRIMIDO
Dose
0,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Psicótropos
Commercialized
No
Company Name
Aurovitas Spain, S.A.U.
Active Ingredients
LORAZEPAM
0,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 16, 2025
Approval ID
715b6baaaf59598c
Type
Standard
Back to CIMA-AEMPS Approvals
